Adverse events with sodium-glucose co-transporter-2 inhibitors: a global analysis of international spontaneous reporting systems

We assessed post-marketing safety of sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) by analyzing adverse events (AEs) reported in international pharmacovigilance databases.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - October 17, 2017 Category: Nutrition Authors: E. Raschi, M. Parisotto, E. Forcesi, M. La Placa, G. Marchesini, F. De Ponti, E. Poluzzi Source Type: research